Last 2.80 MYR
Change Today -0.04 / -1.41%
Volume 76.3K
As of 11:32 PM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

karex bhd (KAREX) Snapshot

Open
2.78
Previous Close
2.84
Day High
2.80
Day Low
2.76
52 Week High
04/15/14 - 3.52
52 Week Low
11/5/13 - 1.23
Market Cap
1.1B
Average Volume 10 Days
562.8K
EPS TTM
0.15
Shares Outstanding
405.0M
EX-Date
--
P/E TM
19.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for KAREX BHD (KAREX)

Related News

No related news articles were found.

karex bhd (KAREX) Related Businessweek News

View More BusinessWeek News

karex bhd (KAREX) Details

Karex Berhad, through its subsidiaries, manufactures and sells condoms under the Carex and INNO brand names. It also provides urethral catheters under the CHROMA, ProCare, and UroCare brand names for the drainage of fluid from the bladder; latex probe covers for hygienic protection in patients during ultrasonic examinations; and lubricating jellies, as well as rubber finger gloves, hand gloves, and latex sleeves. The company markets its products to brand owners, institutional buyers, and distributors and traders primarily in the United States, Africa, Asia, and Europe. Karex Berhad was founded in 1988 and is based in Port Klang, Malaysia.

Founded in 1988

karex bhd (KAREX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

karex bhd (KAREX) Key Developments

Karex Berhad Proposes Dividend for the Financial Year Ended June 30, 2014

The Board of Directors of Karex Berhad announced that the company intends to seek the approval from its shareholders for proposed final single-tier dividend of 2.5 sen per ordinary share of MYR 0.25 each in respect of the financial year ended June 30, 2014 at the forthcoming Annual General Meeting of the company.

Karex Berhad Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2014

Karex Berhad reported unaudited consolidated earnings results for the fourth quarter and full year ended June 30, 2014. For the quarter, the company reported revenue of MYR 63,136,000. Results from operating activities were MYR 13,750,000 compared to loss from operating activities of MYR 158,000 a year ago. Profit before tax was MYR 13,598,000 compared to loss before tax of MYR 158,000 a year ago. Profit attributable to owners of the parent was MYR 12,203,000 or 3.01 sen per basic and diluted share compared to loss attributable to owners of the parent of MYR 158,000 or 1,975,000 sen per basic and diluted share a year ago. For the year, the company reported revenue of MYR 219,927,000. Results from operating activities were MYR 41,770,000 compared to loss from operating activities of MYR 632,000 a year ago. Profit before tax was MYR 41,541,000 compared to loss before tax of MYR 632,000 a year ago. Profit attributable to owners of the parent was MYR 34,585,000 or 14.55 sen per basic and diluted share compared to loss attributable to owners of the parent of MYR 632,000 or 9,028,571 sen per basic and diluted share a year ago. Net cash flow from operating activities was MYR 25,412,000. Acquisition of property, plant and equipment was MYR 9,950,000. The higher revenue and profit before tax reported was attributed to higher volume of condom sales achieved as a result of the installation of additional manufacturing capacity for condom manufacturing.

Karex Berhad Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Karex Berhad reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company reported revenue of MYR 74.62 million. Results from operating activities were MYR 13.25 million compared to loss from operating activities of MYR 0.157 million a year ago. Profit before tax was MYR 13.46 million compared to loss before tax of MYR 0.157 million a year ago. Profit attributable to owners of the parent was MYR 11.54 million or 4.21 sen per basic and diluted share compared to MYR 0.157 million or 0.00 sen per basic and diluted share a year ago. For the nine months, the company reported revenue of MYR 156.79 million. Results from operating activities were MYR 28.02 million compared to loss from operating activities of MYR 0.474 million a year ago. Profit before tax was MYR 27.94 million compared to loss before tax of MYR 0.474 million a year ago. Profit attributable to owners of the parent was MYR 22.38 million or 12.28 sen per basic and diluted share compared to MYR 0.474 million or 0.00 sen per basic and diluted share a year ago. Net cash flow from operating activities was MYR 23.99 million. Acquisition of property, plant and equipment was MYR 7.82 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KAREX:MK 2.80 MYR -0.04

KAREX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KAREX.
View Industry Companies
 

Industry Analysis

KAREX

Industry Average

Valuation KAREX Industry Range
Price/Earnings 24.9x
Price/Sales 5.2x
Price/Book 5.1x
Price/Cash Flow 33.1x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAREX BHD, please visit www.karex.com.my. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.